Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND Neurokinin
25 results:

  • 1. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
    Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
    Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells.
    Xiang H; Toyoshima Y; Shen W; Wang X; Okada N; Kii S; Sugiyama K; Nagato T; Kobayashi H; Ikeo K; Hashimoto S; Tanino M; Taketomi A; Kitamura H
    Cancer Sci; 2022 Aug; 113(8):2513-2525. PubMed ID: 35561088
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells.
    Golestaneh M; Firoozrai M; Javid H; Hashemy SI
    Mol Biol Rep; 2022 Jun; 49(6):4893-4900. PubMed ID: 35429316
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of the Oncology Care Model on Use of Supportive Care Medications During cancer Treatment.
    Brooks GA; Landrum MB; Kapadia NS; Liu PH; Wolf R; Riedel LE; Hsu VD; Jhatakia Parekh S; Simon C; Hassol A; Keating NL
    J Clin Oncol; 2022 Jun; 40(16):1763-1771. PubMed ID: 35213212
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk.
    Shimokawa M; Hayashi T; Nishimura J; Satoh T; Fukunaga M; Matsui R; Tsuji Y; Mizuki F; Kogawa T
    BMC Cancer; 2021 Oct; 21(1):1111. PubMed ID: 34656107
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in colorectal cancer.
    Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C
    Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.
    De Luca R; Volpe C; Mistretta O; Paci R; Ferrera G; Caputo V; Rosati G; Cicero G
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5310-5317. PubMed ID: 34486707
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Investigation of the Role of neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
    Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
    Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy-induced nausea and vomiting: A prospective cohort study.
    Park HS; Won HS; An HJ; Cho SS; Kim HH; Sun S; Ko YH; Shim BY
    Cancer Med; 2021 Feb; 10(3):1057-1065. PubMed ID: 33369184
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 5HT
    Hayashi T; Shimokawa M; Matsuo K; Nishimura J; Iihara H; Nakano T; Egawa T
    Cancer Sci; 2021 Feb; 112(2):744-750. PubMed ID: 33274555
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk factors of chemotherapy-induced nausea and vomiting in patients with metastatic colorectal cancer: a prospective cohort study (YCOG1301).
    Takei S; Ishibe A; Watanabe J; Watanabe K; Suwa Y; Suzuki S; Nakagawa K; Suwa H; Ota M; Ichikawa Y; Kunisaki C; Yamanaka T; Endo I
    Int J Colorectal Dis; 2020 Dec; 35(12):2323-2329. PubMed ID: 32860080
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
    Lorestani S; Ghahremanloo A; Jangjoo A; Abedi M; Hashemy SI
    Mol Biol Rep; 2020 May; 47(5):3469-3474. PubMed ID: 32277443
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations.
    Rapoport BL; Aapro M; Chasen MR; Jordan K; Navari RM; Schnadig I; Schwartzberg L
    Drug Des Devel Ther; 2017; 11():2621-2629. PubMed ID: 28919712
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Basic and translational research progress of gastrointestinal neuroendocrine neoplasmas].
    Song Y; Li X; Song T; Lin G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1217-1221. PubMed ID: 27928788
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prescription of Prophylactic Antiemetic Drugs for Patients Receiving Chemotherapy With Minimal and Low Emetic Risk.
    Okuyama A; Nakamura F; Higashi T
    JAMA Oncol; 2017 Mar; 3(3):344-350. PubMed ID: 27812688
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
    Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
    Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.
    Nishimura J; Satoh T; Fukunaga M; Takemoto H; Nakata K; Ide Y; Fukuzaki T; Kudo T; Miyake Y; Yasui M; Morita S; Sakai D; Uemura M; Hata T; Takemasa I; Mizushima T; Ohno Y; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M;
    Eur J Cancer; 2015 Jul; 51(10):1274-82. PubMed ID: 25922233
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
    Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
    World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors.
    Di Maio M; Bria E; Banna GL; Puglisi F; Garassino MC; Lorusso D; Perrone F
    Anticancer Drugs; 2013 Feb; 24(2):99-111. PubMed ID: 23165435
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
    Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF; Becker JM
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17420-5. PubMed ID: 21969570
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.